Atorvastatin decrease GATA4 and MEF2C transcription factors in human cardiac fibroblasts
BackBibliographic information
- Publication year
- 2022
- Category
- V3 — Scientific output of publication activity from the journal
- CREPČ / EPCA ID
- 0040354
- Document type
- Journal article
- Source
- European Pharmaceutical Journal
- ISSN (Source)
- 2453-6725
- Volume
- Vol. 69, suppl. 1 (2022), p. 43
- Source publication year
- 2022
- Output type
- abstract from the event
- Language
- English
- Study field
- pharmacyField group: Health sciences and fields aimed at improving the quality of life
- Research areas
- 180 — Medical, pharmaceutical and non-medical health sciences
- Links
Bibliographic record
CHOMANIČOVÁ, Nikola - ADAMIČKOVÁ, Adriana - VALÁŠKOVÁ, Simona - MOLITORISOVÁ, Miroslava - GAŽOVÁ, Andrea - KYSELOVIČ, Ján. Atorvastatin decrease GATA4 and MEF2C transcription factors in human cardiac fibroblasts. In: Česko-slovenské farmakologické dni. European Pharmaceutical Journal : Acta Facultatis Pharmaceuticae Universitatis Comenianae. 2022. ISSN 2453-6725, Vol. 69, suppl. 1 (2022), p. 43. (8 - H-index, 0.138 - SJR, Q4 - SJR Best Q).
Publication authors
| Author | Role | Share |
|---|---|---|
| Nikola Chomaničová | Author | 0.000 % |
| Adriana Adamičková | Author | 0.000 % |
| Simona Valášková | Author | 0.000 % |
| Miroslava Molitorisová | Author | 0.000 % |
| Andrea Gažová | Author | 0.000 % |
| Ján Kyselovič | Author | 0.000 % |
Metrics
SJR Q 4SJR 0.138H-index 8Metrics year 2021